Cargando…

Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study

BACKGROUND: We anticipate large efficacy trials of novel HIV vaccines that have shown acceptable safety profiles. We determined willingness to participate (WTP) in future HIV vaccine efficacy trials among HIV negative female sex workers (FSWs) in Kampala Uganda. METHODS: We conducted a case control...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayanja, Yunia, Abaasa, Andrew, Namale, Gertrude, Price, Matt A., Kamali, Anatoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686944/
https://www.ncbi.nlm.nih.gov/pubmed/33239018
http://dx.doi.org/10.1186/s12889-020-09932-7
_version_ 1783613429744926720
author Mayanja, Yunia
Abaasa, Andrew
Namale, Gertrude
Price, Matt A.
Kamali, Anatoli
author_facet Mayanja, Yunia
Abaasa, Andrew
Namale, Gertrude
Price, Matt A.
Kamali, Anatoli
author_sort Mayanja, Yunia
collection PubMed
description BACKGROUND: We anticipate large efficacy trials of novel HIV vaccines that have shown acceptable safety profiles. We determined willingness to participate (WTP) in future HIV vaccine efficacy trials among HIV negative female sex workers (FSWs) in Kampala Uganda. METHODS: We conducted a case control study in the Good Health for Women Project cohort. Cases received HIV prevention services and, enrolled in a 12-month simulated vaccine efficacy trial (SiVET) that used Hepatitis B vaccine; they underwent vaccine trial procedures as would be in an actual trial. Controls received similar health services but did not enroll in SiVET. We matched cases and controls (ratio 2:1) for age and duration in the cohort. We described a hypothetical HIV vaccine trial to cases (after 9 months in SiVET) and controls including trial attributes: randomization, delaying pregnancy, frequent blood draws (80-100mls) and study visits for 3 years. We compared WTP and willingness for vaccine trial attributes by case/control using chi-squared or Fisher’s exact tests and fitted conditional logistic regression models to determine independent predictors of WTP. RESULTS: We analyzed data for 311 volunteers (219 cases, 92 controls); median age 27 years (IQR: 23–32), 39.9% had ≥secondary education, 57.9% had sex work as their main job and 81.9% used illicit drugs. Compared to controls, more cases had lived in the community for > 1 year, (85.4% vs 64.1%; p < 0.001) and fewer cases reported illicit drug use in the past 3 months, (79.0% vs 89.1%; p = 0.03). Overall, 278 (89.4%) volunteers expressed WTP in an HIV vaccine trial, the most common reason being hope of protection against HIV. More cases than controls (58.2% vs 44.7%) did not need to consult anyone before trial participation (p = 0.03); cases were more willing to delay pregnancy (99.0% vs 94.0%; p = 0.03). Combining vaccine trial attributes, 249 (89.6%) of the 278 accepted all attributes. After controlling for case/ control status women with secondary education or higher expressed less WTP (aOR 0.17; 95% CI 0.04–0.80). CONCLUSION: FSWs in Kampala demonstrated high WTP. Prior experience with trial requirements like contraception may improve their uptake during actual trials. Family involvement is important for those without prior trial experience.
format Online
Article
Text
id pubmed-7686944
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76869442020-11-25 Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study Mayanja, Yunia Abaasa, Andrew Namale, Gertrude Price, Matt A. Kamali, Anatoli BMC Public Health Research Article BACKGROUND: We anticipate large efficacy trials of novel HIV vaccines that have shown acceptable safety profiles. We determined willingness to participate (WTP) in future HIV vaccine efficacy trials among HIV negative female sex workers (FSWs) in Kampala Uganda. METHODS: We conducted a case control study in the Good Health for Women Project cohort. Cases received HIV prevention services and, enrolled in a 12-month simulated vaccine efficacy trial (SiVET) that used Hepatitis B vaccine; they underwent vaccine trial procedures as would be in an actual trial. Controls received similar health services but did not enroll in SiVET. We matched cases and controls (ratio 2:1) for age and duration in the cohort. We described a hypothetical HIV vaccine trial to cases (after 9 months in SiVET) and controls including trial attributes: randomization, delaying pregnancy, frequent blood draws (80-100mls) and study visits for 3 years. We compared WTP and willingness for vaccine trial attributes by case/control using chi-squared or Fisher’s exact tests and fitted conditional logistic regression models to determine independent predictors of WTP. RESULTS: We analyzed data for 311 volunteers (219 cases, 92 controls); median age 27 years (IQR: 23–32), 39.9% had ≥secondary education, 57.9% had sex work as their main job and 81.9% used illicit drugs. Compared to controls, more cases had lived in the community for > 1 year, (85.4% vs 64.1%; p < 0.001) and fewer cases reported illicit drug use in the past 3 months, (79.0% vs 89.1%; p = 0.03). Overall, 278 (89.4%) volunteers expressed WTP in an HIV vaccine trial, the most common reason being hope of protection against HIV. More cases than controls (58.2% vs 44.7%) did not need to consult anyone before trial participation (p = 0.03); cases were more willing to delay pregnancy (99.0% vs 94.0%; p = 0.03). Combining vaccine trial attributes, 249 (89.6%) of the 278 accepted all attributes. After controlling for case/ control status women with secondary education or higher expressed less WTP (aOR 0.17; 95% CI 0.04–0.80). CONCLUSION: FSWs in Kampala demonstrated high WTP. Prior experience with trial requirements like contraception may improve their uptake during actual trials. Family involvement is important for those without prior trial experience. BioMed Central 2020-11-25 /pmc/articles/PMC7686944/ /pubmed/33239018 http://dx.doi.org/10.1186/s12889-020-09932-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Mayanja, Yunia
Abaasa, Andrew
Namale, Gertrude
Price, Matt A.
Kamali, Anatoli
Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study
title Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study
title_full Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study
title_fullStr Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study
title_full_unstemmed Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study
title_short Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study
title_sort willingness of female sex workers in kampala, uganda to participate in future hiv vaccine trials: a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686944/
https://www.ncbi.nlm.nih.gov/pubmed/33239018
http://dx.doi.org/10.1186/s12889-020-09932-7
work_keys_str_mv AT mayanjayunia willingnessoffemalesexworkersinkampalaugandatoparticipateinfuturehivvaccinetrialsacasecontrolstudy
AT abaasaandrew willingnessoffemalesexworkersinkampalaugandatoparticipateinfuturehivvaccinetrialsacasecontrolstudy
AT namalegertrude willingnessoffemalesexworkersinkampalaugandatoparticipateinfuturehivvaccinetrialsacasecontrolstudy
AT pricematta willingnessoffemalesexworkersinkampalaugandatoparticipateinfuturehivvaccinetrialsacasecontrolstudy
AT kamalianatoli willingnessoffemalesexworkersinkampalaugandatoparticipateinfuturehivvaccinetrialsacasecontrolstudy